Investor Relations | Corporate Information

October 1, 2026	Nippon Chemiphar to Get Marketing Authorization for Mucosolvan® Expectorants in Japan (pdf, 129KB)
September 14, 2026	New DropScreen Products Launched -Allow Faster Allergy Testing-(pdf, 101KB)
August 31, 2026	Corporate Report 2026 (Annual Report FY2025) (pdf, 1.3MB)
August 17, 2026	DropScreen New Allergy Screening Kit and Reagent Approved — Faster Test Results with New Kit–Reagent Combination — (pdf, 106KB)
July 31, 2026	Summary of Consolidated Financial Results for the First Quarter of FY2026. (pdf, 175KB)
July 31, 2026	First quarter business summary FY2026. (pdf, 635KB)
May 15, 2026	Summary of Consolidated Financial Results for the FY2025. (pdf, 167KB)
May 15, 2026	Business summary FY2025. (pdf, 717KB)
May 13, 2026	Revision of FY2025 Forecasts. (pdf, 92KB)
January 30, 2026	Summary of Consolidated Financial Results for the Third Quarter of FY2025. (pdf, 205KB)
January 30, 2026	Third quarter business summary FY2025. (pdf, 575KB)
January 15, 2026	Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression. (pdf, 154KB)
October 31, 2025	Summary of Consolidated Financial Results for the Second Quarter of FY2025. (pdf, 187KB)
October 31, 2025	Second quarter business summary FY2025. (pdf, 1.0MB)
August 29, 2025	Corporate Report 2025 (Annual Report FY2024) (pdf, 1.2MB)

IR Calendar